Introduction
The two major essential fatty acids (E.F.A.) found in man are linoleic acid and arachidonic acid. Both are impor,tanrt constituents of cell membranes. Arachidonic acid is synthesized from linoleic acid in the liver but man, in common with all other vertebrates lacks the ability ito synthesize linoleic acid de novo. Yeasts and plants, however, have enzymes capable of inserting the double bond between the sixth and seventh carbon atoms of a fatty acid chain (counting from the methyl end) which is -the characteristic feature of both these essential fatty acids. Some of the commoner fatty acids found in man and the nomenclature used to describe them are shown in table I. All belong to the )6 series. Thus Conversion of linoleic acid (18:2 c6) to arachidonic acid (20:4 0)6) takes place via the formation of 8, 11, 14-eicosatrienoic acid (20:3 06) , whereas in essential fatty acid deficiency this process ceases and instead oleic acid (18:1 0)9) is converted to 5, 8, 11-eicosatrenoic acid (20:3 0)9). The presence of significant amounts of the latter in plasma or tissue phospholipids is regarded as the biochemical hallmark of E.F.A. deficiency. Absence of E.F.A. from the diet has long been known to give rise to a specific deficiency syndrome in young animals, who fail to grow normally, develop a scaly dermatitis, and have widespread metabolic disturbances (Holman, 1971) . A similar syndrome has been described in human infants fed miLk formulae containing only saturated fat (Hansen et al., 1963) , but the first adult case has only recently been described (Collins et al., 1971) . In that case and in other even more recent reports (Caldwell et al., 1972; Paulsrud et al., 1972; Jeejeebhoy et al., 1973) 
Results
The percentage of non-essential and essential fatty acids in the triglyceride, cholesterol ester, and lecithin fractions of whole plasma from the -three patients, one of whom was studied on two separate occasions, is shown in fig. 1 Mead, 1971) .
Under normal circumstances lineoleic acid inhibits,the synthesis of 5, 8, 11-eicosatrienoic acid from oleic acid ( fig. 3 ). In the presence of severe linoleic acid deficiency however, not only is arachidonic acid synthesis decreased but the synthesis of 5, 8, 11-eicosatrienoic acid is no longer inhibited, leading to its appearance in plasma lecithin. These changes can be quantitated by calculating the ratio 20:3 9. All our patients 20:4 ptet had ratios of 0 4 or over, which is regarded as pathognomonic of E F.A. deficiency (Holman 1971 to Y-linolenic acid (18:3), to 8,11,14-eicosatrienoic acid (20:3u06), to arachidonic acid (20:4), and thence to prostaglandins (Mead, 1971; Samuelsson, 1972) . Same enzyme system can convert oleic acid (18:1) to 5,8,11-eicosatrienoic acid (Mead, 1971) . Neither 18:2o9 nor 20:3co9 have any of the biological activity of their ca6 isomers.
nosed and when oral supplementation of the diet is impractical.
What are the metabolic consequences of E.F.A. deficiency in man? A scaly rash has been prominent both in experimental animals and in h-umans, and was present in our patient who had the most severe E.F.A. deficiency. It disappeared af,ter the administration of Intralipid. Essential fatty acids are precursors of -the prostaglandins (Samuelsson, 1972) , so it is interesting that the skin lesions of E.F.A. deficiency respond to the topical application of prostaglandin E2 (Ziboh and Hsai, 1972) . Prostaglandins are also known to influence platelet function in vitro, and itt has been suggested ,that the increased tendency to platelet aggregation in rats (Hornstra, 1971 ) and in man (Homsstra et al., 1973) when fed diets low in linoleic acid may be due to reduced prostaglandin synthesis. Furthermore, E.F.A. deficiency has been shown to be associated with increased pla-telet adhesiveness and sensitivity to adenosine diphosphate-induced aggregation in vi-tro (Caldwell et al., 1972; Press et al., 1974 a ) . It may therefore be relevant that ,the most severely E.F.A.-deficient of our patients (case 3) has had two cerebral and two coronary arterial occlusions since her intestinal resection. The first, immediately after the operation, may have been related to dehydration but the other three were unexplained.
Because of itheir malabsorption patients with intestinal resection.s are in precarious metabolic balance. E.F.A. deficiency in rats causes structural changes in the intestinal mucosa (Snipes, 1968) and ithese are associated with malabsorption of sugars, amino-acids and fat (Snipes, 1968; Imami et al., 1970; Clark et al., 1973) . Thus E.F.A. deficiency may further aggravate pre-existing malabsorption. Furthermore, widespread structural and functional disorganization of mi,tochondria (Wilson and Leduc, 1963) leads to an increase in the basal metabolic rate (Soderhjelm et al., 1971) (Sinclair and Collins, 1968) and is a probable cause of the fatty liver sometimes seen after intestinal reseotion in humans (van Tongeren et al., 1972 
Summary
The bronchodilator and cardiac effects produced by aerosols of 0G5% salbutamol and 0(5% and 1% rimiterol administered for three minutes in 40% oxygen by intermittent positivepressure ventilation (I.P.P.V.) were compared in 15 asthmatic patients. Salbutamol and both the concentrations of rimiterol were equipotent in peak bronchodilator effect, but salbutamol had a significantly longer duration of bronchodilator action. There was significantly less increase in heart rate after rimiterol than after salbutamoL Aerosols of 0-5% rimiterol, 0 5% Introduction Rimiterol-erythro-(3, 4 dihydroxyphenyl (2-piperidyl) methanol hydrobromide-is a member of a new series of sympathomimetic amines, the aryl-2-piperidyl carbinols (Sankey and Whiting, 1972) , in which the side chain is cyclized around the alpha-carbon atom to form a piperidyl ring. Invitro and in-vivo animal studies have shown rimiterol to have a preferential bronchodilator action with less cardiovascular activity than isoprenaline (Laity, 1971; Carney et al., 1971; Bowman and Rodger, 1972; Gailer et al., 1971 ). Studies in volunteers and patients with asthma have shown riniiterol and isoprenaline equipotent weight-for-weight as bronchodilators (Turner and Griffin, 1971; Shenfield and Paterson, 1973) , but rimiterol has been reported to have less chronotropic action on the heart than isoprenaline, Svedmyr et al., Griffin et al., 1973) and salbutamol (Phillips et al., 1972) .
This investigation was planned to compare the bronchodilator properties and cardiac stimulant effects of rimiterol and salbutamol when administered by intermittent positivepressure ventilation (I.P.P.V.) using the technique described by Choo-Kang et al. (1970) . Since these workers concluded that a 05% solution of salbutamol delivered by I.P.P.V. for three minutes provided "maximum bronchodilatation without important tachycardia" the same concentration of salbutamol was used in this study for comparison with rimiterol in 0 5% and 1% solutions.
Patients and Methods
The plan of the trial was similar to that described by ChooKang et al. (1970) . Fifteen patients received for periods of three minutes on consecutive days aerosols of 05% rimiterol, 1 % rimiterol, and 0 5 % salbutamol and 40 % oxygen delivered during each inspiraitory cycle by I.P.P.V. from a Bennett ventilator. Patients received one of the treatments on each of three consecutive days. The sequence of drug administration was determined by a latin square experimental design.
The identity of the drug and its concentration were unknown to the patient and medical observers. The highest of three readings of forced expiratory volume in one second (FEV1) from a Gaensler spirometer was recorded at 10 minutes, five minutes, and one minute before treatment and at 5, 15, 30, 60, 120, 180 , and 240 minutes after treatment. The heart rate was read from a Hewlett-Packard cardiac monitor immediately before drug administration, at 5-minute intervals for 60 minutes afterwards, and thereafter at hourly intervals for the next three hours. The electrocardiograph was observed for arrhythmias during and for one hour after drug administration.
Ten normal volunteers were also studied in a subsidiary investigation and each received on consecutive days 05 % rimiterol, 0 5% salbutamol, and saline. The sequence of drug administration was randomnized and procedures and measure-
